Estimating lymphodynamic conditions and lymphovenous anastomosis efficacy using 99mTc-phytate lymphoscintigraphy with SPECT-CT in patients with lower-limb lymphedema

Plastic and Reconstructive Surgery - Global Open

Volumn 3, Issue 5, 2015, Pages

  Iimura, Takeshi ^a   Fukushima, Yoshimitsu ^a   Kumita, Shinichiro ^a   Ogawa, Rei ^a   Hyakusoku, Hiko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84959366293     PISSN: None     EISSN: 21697574     Source Type: Journal    
DOI: 10.1097/GOX.0000000000000375     Document Type: Article

References (22)

1. Nawaz K, Hamad M, Sadek S, et al. Lymphscintigraphy in peripheral lymphedema using technetium-labelled human serum albumin: normal and abnormal patterns. Lymphology 1985;18:181–186.
2. Suehiro K, Morikage N, Murakami M, et al. Re-evaluation of qualitative lymphangioscintigraphic findings in secondary lower extremity lymphedema. Surg Today 2014;44:1048–1055.
3. Szuba A, Shin WS, Strauss HW, et al. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43–57.
4. Maegawa J, Mikami T, Yamamoto Y, et al. Types of lymphoscintigraphy and indications for lymphaticovenous anastomosis. Microsurgery 2010;30:437–442.
5. 99mTc-phytate efficiency. Breast Cancer Res Treat. 2010;122:453–457.
6. Blum KS, Radtke C, Knapp WH, et al. SPECT-CT: a valuable method to document the regeneration of lymphatics and autotransplanted lymph node fragments. Eur J Nucl Med Mol Imaging 2007;34:1861–1867.
7. Pecking AP, Wartski M, Cluzan RV, et al. SPECT-CT fusion imaging radionuclide lymphoscintigraphy: potential for limb lymphedema assessment and sentinel node detection in breast cancer. Cancer Treat Res. 2007;135:79–84.
8. O’Brien BM, Sykes P, Threlfall GN, et al. Microlymphaticovenous anastomoses for obstructive lymphedema. Plast Reconstr Surg. 1977;60:197–211.
9. Campisi C, Davini D, Bellini C, et al. Lymphatic microsurgery for the treatment of lymphedema. Microsurgery 2006;26:65–69.
10. Campisi C, Eretta C, Pertile D, et al. Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery 2007;27:333–338.
11. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46:1–11.
12. Yamamoto T, Matsuda N, Todokoro T, et al. Lower extremity lymphedema index: a simple method for severity evaluation of lower extremity lymphedema. Ann Plast Surg. 2011;67:637–640.
13. Unno N, Inuzuka K, Suzuki M, et al. Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. J Vasc Surg. 2007;45:1016–1021.
14. Yamamoto T, Narushima M, Doi K, et al. Characteristic indocyanine green lymphography findings in lower extremity lymphedema: the generation of a novel lymphedema severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;127:1979–1986.
15. Yamamoto T, Matsuda N, Doi K, et al. The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg. 2011;128:314e–321e.
16. O’Mahony S, Britton TB, Ballinger JR, et al. Delivery of radio-labelled blood cells to lymphatic vessels by intradermal injection: a means of investigating lymphovenous communications in the upper limb. Nucl Med Commun. 2010;31:121–127.
17. Edwards JM, Kinmonth JB. Lymphovenous shunts in man. Br Med J. 1969;4:579–581.
18. Stamp GF, Peters AM. Peripheral lymphovenous communication in lymphoedema. Nucl Med Commun. 2012;33:701–707.
19. Alavi A, Staum MM, Shesol BF, et al. Technetium-99m stannous phytate as an imaging agent for lymph nodes. J Nucl Med. 1978;19:422–426.
20. Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link? Plast Reconstr Surg. 2014;134:154e–160e.
21. Martel C, Li W, Fulp B, et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest. 2013;123:1571–1579.
22. Lim HY, Rutkowski JM, Helft J, et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol. 2009;175:1328–1337.